NDUFA9P1

Across TCGA pan-cancer cohorts, NDUFA9P1 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of NDUFA9P1’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where NDUFA9P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types NDUFA9P1 is over-expressed in tumor, although a few such as ESCA show the opposite, repressed pattern.

HNSC, COAD, and BLCA are the cancer types where NDUFA9P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in NDUFA9P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	III,IV	+0.106	.002	7	view →
COAD	All	All	+0.291	<.001	6	view →
BLCA	All	All	+0.272	.023	4	view →
LIHC	All	All	+0.056	<.001	4	view →
LUSC	All	All	+0.109	.001	3	view →
CHOL	All	All	+0.114	.010	2	view →
ESCA	Female	All	−0.659	<.001	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

NDUFA9P1–HNSC

Open the HNSC breakdown →